BIOCHINA and Life Science Nation Team Up to Advance China–Global Biotech Partnerships

Collaboration connects Chinese innovation with international licensing partners at RESI JPM and BIOCHINA 2027

By Dennis Ford, Founder & CEO, Life Science Nation (LSN)

BOSTON and SUZHOU, China — Chinese biotech is changing the global partnering landscape. Life Science Nation (LSN) and Enmore BIO, organizer of BIOCHINA, are teaming up in 2027 to connect the companies driving that change with international licensing partners seeking their next opportunity.

The collaboration launches during J.P. Morgan Healthcare Week at RESI JPM, January 11–12 at the San Francisco Marriott Marquis, and continues at BIOCHINA, March 10–12 in Suzhou. Through reciprocal programs and coordinated outreach, the organizations will bring their communities together across two major life science gatherings. At RESI JPM, BIOCHINA will lead a one-hour China-focused session exploring how AI, innovation capabilities, and evolving partnership models are shaping the next generation of Chinese biotech. The discussion will bring Chinese industry leaders into direct conversation with RESI’s global licensing and partnering community about emerging technologies, business opportunities, and international collaboration.

At BIOCHINA, LSN will lead a reciprocal one-hour session on how international partners evaluate emerging companies, assess the team behind the science, and build productive relationships with founders. Final session titles and speakers will be announced separately.

“Both communities are looking across borders for their next opportunity,” said Dennis Ford, Founder and CEO of Life Science Nation. “Chinese companies are developing assets that global pharma is evaluating for future pipelines. International companies are seeking scientific relationships, development capabilities, and partners in China. Our job is to bring the right people together and help those conversations turn into business.”

The collaboration gives both organizations a platform to build a two-way innovation bridge—helping Chinese companies reach international markets while opening connections into China for global companies and strategic partners. Joint promotion through newsletters, industry networks and digital channels will extend the programs’ reach and introduce participants to opportunities across both communities.

The relationship has a proven starting point: LSN and Enmore Healthcare co-organized the first RESI Shanghai on November 12, 2019. Their 2027 collaboration brings those networks together again to advance the next generation of international partnerships.

About Life Science Nation

Life Science Nation connects emerging companies across drugs, devices, diagnostics and digital health with global investors and licensing partners through its databases, education, investability assessments, campaign services and RESI conference series.

About BIOCHINA

Founded in 2016, BIOCHINA has grown into the Asia-Pacific’s leading biotech industry event, with over 33,000 registered attendees by 2026. Centered on evolving industry needs, BIOCHINA integrates Exhibition, Conference, Partnering, and Events to: Connect supply and demand across the value chain, Share the latest technological trends, Drive project collaborations and funding, Promote global biotech cooperation. Moving forward, BIOCHINA remains committed to connect Innovators & enable Bio-industry.

RESI: https://www.resiconference.com/
BIOCHINA: https://www.biocn.cn/

Leave a Reply